Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Molecular Partners AG (SW: MOLN)

 
MOLN Technical Analysis
4
As on 3rd Dec 2025 MOLN STOCK Price closed @ 3.33 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.53 & Strong Sell for SHORT-TERM with Stoploss of 4.71 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MOLNSTOCK Price

Open 3.18 Change Price %
High 3.45 1 Day 0.12 3.74
Low 3.18 1 Week 0.16 5.05
Close 3.33 1 Month 0.49 17.25
Volume 61653 1 Year -1.91 -36.45
52 Week High 5.24 | 52 Week Low 2.75
 
SW Switzerland Most Active Stocks
CSGN 0.82 0.00%
CSGN 0.82 0.00%
UBSG 30.85 -0.68%
UBSG 30.85 -0.68%
NOVN 107.40 1.13%
NOVN 107.40 1.13%
NESN 78.52 -0.61%
NESN 78.52 -0.61%
SIGN 9.27 0.32%
PRFN 0.03 50.00%
 
SW Switzerland Top Gainers Stocks
PRFN 0.03 50.00%
PRFN 0.03 50.00%
CADN 0.03 50.00%
COPN 78.30 19.54%
BLS 0.13 18.18%
BLS 0.13 18.18%
BLS 0.13 18.18%
NEWN 0.94 17.50%
CIE 0.21 16.67%
CIE 0.21 16.67%
 
SW Switzerland Top Losers Stocks
AFP 1.00 -93.75%
AFP 1.00 -93.75%
AFP 1.00 -93.75%
ZWM 146.00 -18.89%
SHLTN 0.74 -17.78%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
CON 98.00 -12.35%
 
 
MOLN
Daily Charts		 MOLN
Intraday Charts		 Whats New @
Bazaartrend		 MOLN
Free Analysis
 
MOLN Important Levels Intraday
RESISTANCE3.85
RESISTANCE3.68
RESISTANCE3.58
RESISTANCE3.48
SUPPORT3.18
SUPPORT3.08
SUPPORT2.98
SUPPORT2.81
 
MOLN Forecast December 2025
Share
4th UP Forecast5.53
3rd UP Forecast4.82
2nd UP Forecast4.39
1st UP Forecast3.95
1st DOWN Forecast2.71
2nd DOWN Forecast2.27
3rd DOWN Forecast1.84
4th DOWN Forecast1.13
 
MOLN Weekly Forecast
4th UP Forecast3.93
3rd UP Forecast3.74
2nd UP Forecast3.62
1st UP Forecast3.50
1st DOWN Forecast3.16
2nd DOWN Forecast3.04
3rd DOWN Forecast2.92
4th DOWN Forecast2.73
 
MOLN Forecast2025
4th UP Forecast8.32
3rd UP Forecast6.72
2nd UP Forecast5.73
1st UP Forecast4.74
1st DOWN Forecast1.92
2nd DOWN Forecast0.93
3rd DOWN Forecast-0.06
4th DOWN Forecast-1.66
 
 
MOLN Other Details
Segment EQ
Market Capital 567939712.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MOLN Address
MOLN
 
MOLN Latest News
 
Your Comments and Response on Molecular Partners AG
 
MOLN Business Profile
Molecular Partners AG operates as a clinical-stage biopharmaceutical company. It is developing Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of wet age-related macular degeneration, as well as for diabetic macular edema; and MP0250 that binds and inhibit vascular endothelial growth factor and hepatocyte growth factor pathways, which restores clinical sensitivity to various standard-of-care therapies in multiple myeloma. The company is also developing MP0274 that is in Phase I clinical trials for HER2-positive solid tumors; MP0310, which is in Phase I clinical trials for immuno-oncology; MPO317, a tumor-localized immune agonist that activates immune cells in the tumor; and Peptide-MHC, a tumor-localized immune-cell agonist to attack tumors. It has strategic partnerships with Allergan, Inc. and Amgen SA; and collaboration with AGC Biologics to develop anti-COVID-19 DARPin program. Molecular Partners AG was founded in 2004 and is headquartered in Schlieren, Switzerland. Address: Wagistrasse 14, Schlieren, Switzerland, 8952
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service